Search research articles
Contact Us
Filters
Showing results (91-100 of 208) with videos related to
Page
of 21
Sort By:
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
April 26, 2018
Concurrent progressive multifocal leukoencephalopathy and central nervous system infiltration by multiple myeloma: A case report
Yanira Ruiz-Heredia, Beatriz Sanchez-Vega, Santiago Barrio, et al.
Cancer
|
March 27, 2015
Phase 1/1B trial of the heat shock protein 90 inhibitor NVP-AUY922 as monotherapy or in combination with bortezomib in patients with relapsed or refractory multiple myeloma
Ruth Seggewiss-Bernhardt, Ralf C Bargou, Yeow Tee Goh, et al.
Ejhaem
|
September 2, 2022
Transcriptional profiles define drug refractory disease in myeloma
Yuan Xiao Zhu, Laura A Bruins, Xianfeng Chen, et al.
Blood Advances
|
July 12, 2018
Analysis of carfilzomib cardiovascular safety profile across relapsed and/or refractory multiple myeloma clinical trials
Ajai Chari, A Keith Stewart, Stuart D Russell, et al.
Blood
|
August 24, 2011
Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide
Yuan Xiao Zhu, Esteban Braggio, Chang-Xin Shi, et al.
Cancer Cell
|
February 5, 2008
AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies
Marta Chesi, Davide F Robbiani, Michael Sebag, et al.
Blood
|
December 10, 2009
Kinome-wide RNAi studies in human multiple myeloma identify vulnerable kinase targets, including a lymphoid-restricted kinase, GRK6
Rodger E Tiedemann, Yuan Xiao Zhu, Jessica Schmidt, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
May 5, 2026
Medication-related osteonecrosis of the jaw: incidence and risk factors in multiple myeloma patients undergoing pre-autologous stem cell transplant dental extractions
Ji-Eun Deanna Son, Joo Wan James Kim, Sung-Ha Son, et al.
Mayo Clinic Proceedings
|
April 2, 2013
Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013
Joseph R Mikhael, David Dingli, Vivek Roy, et al.
Blood Cancer Discovery
|
March 11, 2026
Debulking Chemotherapy Can Overcome Primary Resistance to Teclistamab in Relapsed Refractory Multiple Myeloma
Rintu Sharma, Andree-Anne Pelland, Katherine Lajkosz, et al.
Page
of 21
Search research articles
Search
Showing results (91-100 of 208) with videos related to
Sort By:
Page
of 21
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
April 26, 2018
Concurrent progressive multifocal leukoencephalopathy and central nervous system infiltration by multiple myeloma: A case report
Yanira Ruiz-Heredia, Beatriz Sanchez-Vega, Santiago Barrio, et al.
Cancer
|
March 27, 2015
Phase 1/1B trial of the heat shock protein 90 inhibitor NVP-AUY922 as monotherapy or in combination with bortezomib in patients with relapsed or refractory multiple myeloma
Ruth Seggewiss-Bernhardt, Ralf C Bargou, Yeow Tee Goh, et al.
Ejhaem
|
September 2, 2022
Transcriptional profiles define drug refractory disease in myeloma
Yuan Xiao Zhu, Laura A Bruins, Xianfeng Chen, et al.
Blood Advances
|
July 12, 2018
Analysis of carfilzomib cardiovascular safety profile across relapsed and/or refractory multiple myeloma clinical trials
Ajai Chari, A Keith Stewart, Stuart D Russell, et al.
Blood
|
August 24, 2011
Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide
Yuan Xiao Zhu, Esteban Braggio, Chang-Xin Shi, et al.
Cancer Cell
|
February 5, 2008
AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies
Marta Chesi, Davide F Robbiani, Michael Sebag, et al.
Blood
|
December 10, 2009
Kinome-wide RNAi studies in human multiple myeloma identify vulnerable kinase targets, including a lymphoid-restricted kinase, GRK6
Rodger E Tiedemann, Yuan Xiao Zhu, Jessica Schmidt, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
May 5, 2026
Medication-related osteonecrosis of the jaw: incidence and risk factors in multiple myeloma patients undergoing pre-autologous stem cell transplant dental extractions
Ji-Eun Deanna Son, Joo Wan James Kim, Sung-Ha Son, et al.
Mayo Clinic Proceedings
|
April 2, 2013
Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013
Joseph R Mikhael, David Dingli, Vivek Roy, et al.
Blood Cancer Discovery
|
March 11, 2026
Debulking Chemotherapy Can Overcome Primary Resistance to Teclistamab in Relapsed Refractory Multiple Myeloma
Rintu Sharma, Andree-Anne Pelland, Katherine Lajkosz, et al.
Page
of 21